In CRC, CXCL12/CXCR4 axis activation stimulates the up-regulation of miRNAs on TAMs, leading to enhanced immunosuppression, epithelial to mesenchymal transition (EMT), as well as angiogenesis via VEGF and EGF secretion [103]. The gene discussed is CXCL12; the disease is colorectal carcinoma.